Table 2.
SGLT2i prescribed | Observation |
---|---|
Empagliflozin (%) | 104 (50.7) |
10 mg | 74 (71.1) |
25 mg | 30 (28.9) |
Canagliflozin (%) | 62 (30.2) |
100 mg | 60 (96.8) |
300 mg | 2 (3.2) |
Dapagliflozin (%) | 39 (19.1) |
5 mg | 8 (20.5) |
10 mg | 31 (79.5) |
Duration of treatment with SGLT2i (months) | |
Mean±SD | 7.6±5.9 |
Range | 1-36 |